Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie

What Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie does

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie is a multi-specialty public hospital operating as a single-person limited liability company (sp. z o.o.) wholly owned by the Małopolska Voivodeship government, headquartered at os. Złotej Jesieni 1, Kraków, with a secondary 150-bed long-term care facility in Maków Podhalański. The hospital was founded in December 1993 and restructured into its current corporate form in July 2010. It runs 664 inpatient beds across 23 clinical departments and treats approximately 40,000 inpatients and 150,000+ outpatients annually, with roughly 75% of inpatient volume attributable to oncology services. The institution holds a SOLO III higher-reference oncology center designation — one of only two in Małopolska — and was awarded a 90% accreditation score by the Polish Ministry of Health in December 2025.

The hospital's service portfolio spans oncology, surgery, cardiology, neurology, urology, orthopedics, and mental health, supported by advanced capital equipment including da Vinci and ROSA robotic surgery systems (deployed 2023) and MRI infrastructure. It also operates the Mental Health Center Kraków-Nowa Huta (launched 2022) and is constructing an in-house hospital pharmacy (approx. 80M PLN project). It leads the "Onkologia Małopolska" regional oncology consortium formed in March 2022.

The hospital's revenue model is dominated by contracts with Poland's National Health Fund (NFZ) for publicly insured inpatient and outpatient services, supplemented by commercial/paid services and significant EU and government capital grants for modernization — most notably a 146.4M PLN KPO (National Recovery Plan) grant secured in May 2025 for infrastructure modernization. It is ranked first in Małopolska and third in Poland (Newsweek) for oncology care quality, and employs between 1,001 and 5,000 staff across clinical, administrative, and support functions.

Name

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie

Legal name

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie sp. z o.o.

Website

https://szpitalrydygier.pl

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Rydygier Specialist Hospital in Kraków is a Małopolska Voivodeship-owned multi-specialty public hospital with 664 beds across 23 departments, treating approximately 40,000 inpatients and 150,000+ outpatients annually, with roughly 75% of inpatient volume in oncology under NFZ public-payer contracts.

Ownership category

akta.pro rank

Product category

Multi-Specialty Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

• Specialist hospital services
• Oncology treatment
• Emergency medical care
• Robotic surgery
• Public healthcare

Headquarters

HQ city

Kraków

HQ country

Poland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. NFZ Healthcare Services: Core revenue from National Health Fund (NFZ) contracts for hospital and outpatient services. The hospital is a public healthcare provider with agreements covering all major medical specialties including oncology, surgery, internal medicine, and rehabilitation.
2. Commercial Healthcare Services: Paid specialist consultations, laboratory diagnostics, imaging, procedures, and hotel services available to self-paying patients. Commercial services include obstetric care, rehabilitation, and hotel accommodation.
3. KPO Investment Funding: Krajowy Plan Odbudovy (KPO) funding for modernization projects. Total project budget of 146,439,413.23 PLN with 124,707,279.25 PLN EU funding for diagnostic and oncology facility upgrades.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Core offering

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie is a multi-specialty public hospital delivering comprehensive inpatient and outpatient healthcare services across 23 clinical departments with 664 beds, treating over 40,000 inpatients and ~150,000 outpatients annually. Core offerings include oncology diagnostics and treatment (chemotherapy, radiotherapy via Centrum Radioterapii Amethyst, robotic surgery via da Vinci and ROSA systems), burns and plastic surgery with hyperbaric oxygen therapy, women's health and maternity care, hand rehabilitation, neurology/stroke care, urology, orthopedics, emergency services, long-term nursing care, and approximately 30 NFZ-funded oncology drug programs. The hospital leads the Konsorcjum Onkologia Małopolska regional oncology consortium.

Product overview

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie is a multi-specialty public hospital providing comprehensive medical services through a platform-plus-specialized-centers model. The core offering includes 23 hospital departments with 664 beds treating over 40,000 patients annually, supported by specialized centers including robotic surgery (da Vinci and ROSA systems), Centrum Radioterapii Amethyst for radiotherapy, Małopolskie Centrum Oparzeniowo-Plastyczne with hyperbaric oxygen therapy, Małopolskie Centrum Macierzyństwa i Medycyny Kobiet, Małopolskie Centrum Rehabilitacji Ręki, and Centrum Zdrowia Psychicznego Kraków-Nowa Huta. The hospital operates as a major oncological center with approximately 30 drug therapy programs, fast-track oncological pathway (DILO), cancer prevention programs, and leads the Konsorcjum Onkologia Małopolska consortium. Additional services include clinical research, a clinical trials center, long-term care facility in Maków Podhalański (150 beds), and commercial fee-based services. The hospital's diagnostic infrastructure includes MRI, mammography, endoscopy, laboratory diagnostics, and emergency services. Over 75% of patients are oncological cases, with the hospital ranking as the top oncological facility in Małopolska and among the top 3 in Poland.

Differentiator

Problem solved

Functional benefit

Brands

• Małopolskie Centrum Rehabilitacji Ręki (MCRR): Specialized hand rehabilitation center.
• Małopolskie Centrum Macierzyństwa i Medycyny Kobiet
• Małopolskie Centrum Oparzeniowo-Plastyczne i Replantacji Kończyn z Ośrodkiem Terapii Hiperbarycznej
• Ośrodek Terapii Hiperbarycznej (OTH)
• Centrum Zdrowia Psychicznego Kraków-Nowa Huta
• Centrum Badań Klinicznych
• Ośrodek Onkologiczny 10-lecia w Małopolsce

Products and services

• Robotic Surgery (da Vinci and ROSA systems) Robot-assisted surgical procedures covering general surgery, urology, gynecology, otolaryngology, and orthopedics using da Vinci and ROSA systems. Approximately 500 robotic operations and ~250 robotic knee replacements performed. Available to NFZ-funded public patients and privately.
• Centrum Radioterapii Amethyst (Radiotherapy Center) State-of-the-art radiotherapy center co-located within the hospital complex, providing advanced radiation therapy to oncology patients as part of the integrated cancer care pathway.
• Małopolskie Centrum Oparzeniowo-Plastyczne i Replantacji Kończyn z OTH Leading European center for severe burn treatment, limb replantation, nerve reconstruction, and microsurgical reconstruction, combined with a Hyperbaric Oxygen Therapy Center (OTH). Serves as a national-level replantation service.
• Małopolskie Centrum Macierzyństwa i Medycyny Kobiet Women's health and maternity center offering diagnostics, specialist consultations, prenatal classes, family births, gynecological oncology treatment, and rehabilitation services.
• Małopolskie Centrum Rehabilitacji Ręki (MCRR) Specialized hand rehabilitation center providing comprehensive upper-limb rehabilitation services, including post-replantation therapy.
• Centrum Zdrowia Psychicznego Kraków-Nowa Huta Mental health center operating as a pilot program providing psychological and psychiatric care, including as part of the National Mental Health Protection Program for the Nowa Huta district.
• Zakład Opieki Długoterminowej w Makowie Podhalańskim (Long-Term Care Facility) 150-bed long-term care facility (including mechanical ventilation unit and palliative care) in Maków Podhalański, providing nursing, post-stroke and post-fracture rehabilitation, neurological care, dementia and Alzheimer's care, and psychological, occupational, speech, and physiotherapy services.
• Oddział Onkologii Klinicznej z Pododdziałem Dziennym (Clinical Oncology Department with Day Subdepartment) Clinical oncology department offering chemotherapy, targeted therapy, and immunotherapy. Day sub-department renovated to 24 beds in 2026, providing ~8,500 consultations and 12,122 day hospitalizations annually.
• Oncology Drug Programs (~30 programs) Approximately 30 NFZ-funded drug therapy programs dedicated to specific cancers (gastric, colorectal, lung, kidney, breast, ovarian, melanoma, leukemia, lymphoma) plus multiple sclerosis and Gaucher disease, implemented across 8 hospital departments.
• Szybka Ścieżka Onkologiczna (DILO Fast-Track Oncology Pathway) NFZ fast-track oncology pathway providing rapid diagnosis and treatment coordination for gastrointestinal, head/neck, skin, breast, lung, brain, urological, gynecological, hematological, and musculoskeletal cancers. Approximately 4,000 DILO cards issued annually.
• Konsorcjum Onkologia Małopolska (Oncology Malopolska Consortium) Regional oncology consortium led by Rydygier Hospital with three partner hospitals (Jana Pawła II, św. Łukasza in Tarnów, Jędrzeja Śniadeckiego in Nowy Sącz), coordinating oncology patient care, joint consilia, and registries for breast, colorectal, and prostate cancer.
• Cancer Prevention and Screening Programs Cancer screening programs including cervical cancer prevention, breast cancer prevention, and colorectal cancer screening, financed by the Malopolska NFZ.
• Centrum Badań Klinicznych (Clinical Research Center) Clinical trials facility conducting scientific research across various medical disciplines at the hospital.
• Szpitalny Oddział Ratunkowy (Hospital Emergency Department, SOR) 24/7 emergency department providing immediate care for acute medical conditions, trauma, and life-threatening situations, with 13 paramedics and modern diagnostic equipment including ECG, X-ray, ultrasound, anesthesia machines, ventilators, defibrillators, card monitors, and infusion pumps.
• Zakład Endoskopii (Endoscopy Unit) Endoscopy unit providing diagnostic and therapeutic endoscopic procedures including colonoscopy and gastroscopy.
• Pracownia Rezonansu Magnetycznego (MRI Facility) Modern MRI facility with equipment purchased for 4.73 million PLN, used for diagnostics including post-COVID complications, oncological diagnostics, neurological and cardiovascular conditions, and burn center support.
• Commercial Medical Services (Oferta Komercyjna) Fee-based commercial medical services for self-paying individuals and institutional clients, including specialist consultations, laboratory diagnostics, procedures, peripartum care, rehabilitation, and hotel accommodation; marketed with short waiting times and professional service. Includes a dedicated Biuro Obsługi Pacjenta Komercyjnego (Commercial Patient Service Office).
• Hotel Accommodation for Patients/Families Hotel services for patients and families, offered as a commercial paid service separate from clinical care.

Quantifiable outcome

• Highest oncology service value in all of Malopolska (confirmed by NFZ Kraków, 2021-2022)
• +4 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• Konsorcjum "Onkologia Małopolska" (Oncology Malopolska Consortium)coreStrategic or Co-development Partner · 1 March 2022Consortium led by Szpital Rydygiera including Szpital im. Jana Pawła II, Szpital Wojewódzki im. św. Łukasza w Tarnowie, and Szpital im. Jędrzeja Śniadeckiego w Nowym Sączu. First such initiative in Poland aimed at improving cancer prevention, diagnosis, and treatment coordination across Malopolska. Rydygier serves as consortium leader with Prof. Andrzej Budzyński as head of Medical Council. Includes establishment of joint oncology consilia, registries for breast, colorectal, and prostate cancer treatment.
• Centrum Radioterapii Amethyst (Amethyst Radiotherapy Center)coreStrategic or Co-development PartnerOn-site radiotherapy center co-located within hospital facilities, part of international network specializing in advanced radiotherapy treatments. Provides radiation therapy as part of comprehensive cancer care pathway.
• Szpital im. Jana Pawła II w Krakowie (John Paul II Hospital)coreStrategic or Co-development PartnerConsortium partner in 'Onkologia Małopolska'. Collaboration includes joint interdisciplinary surgeries such as thoracotomy combined with spinal surgery for cancer patients. Prof. Jarosław Kużdżał from thoracotomy department participates in joint operations.
• Szpital Wojewódzki im. św. Łukasza w TarnowiecoreStrategic or Co-development PartnerConsortium partner in 'Onkologia Małopolska'. Prof. Leszek Kołodziejski coordinates 'super-consilia' meetings. Joint development of oncology treatment standards.
• Szpital Specjalistyczny im. Jędrzeja Śniadeckiego w Nowym SączucoreStrategic or Co-development PartnerConsortium partner in 'Onkologia Małopolska'. Dr Robert Bakalarz coordinates chemotherapy scheduling coordination. Contributes to joint oncology registry development.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• LUX MED (Grupa LUX MED): One of Poland's largest private healthcare providers, owned by Bupa, operating hospitals, clinics, and diagnostic centers nationwide. Competes with Rydygier in the commercial segment (consultations, diagnostics, surgical procedures) and represents a growing threat in premium oncology and elective procedures.
• EMC Szpitale (European Medical Center): Leading private hospital chain in Poland with multiple facilities across the country, including in Małopolska. Provides multi-specialty services and competes directly with Rydygier for self-paying patients and commercial segment revenue, with the advantage of newer facilities and more agile commercial operations.

Direct peers

• Szpital Specjalistyczny im. Jędrzeja Śniadeckiego w Nowym Sączu: Consortium partner in Onkologia Małopolska and multi-specialty regional hospital. Provides similar oncology services in the Nowy Sącz sub-region; coordinates chemotherapy scheduling with Rydygier while also being a potential competitor for patients who could travel to either facility.
• Szpital Wojewódzki im. św. Łukasza w Tarnowie: Consortium partner in Onkologia Małopolska and regional multi-specialty hospital serving neighboring Małopolska sub-regions. Collaborates on joint oncology consilia but also competes for oncology patients and NFZ contracts in the broader southern Poland catchment.
• Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie, Oddział w Krakowie (Krakow Branch of National Cancer Institute): Dedicated oncology institute in Krakow with similar comprehensive cancer care services. Direct competitor for oncology referrals, chemotherapy, and radiotherapy in the Małopolska region, including head-to-head competition for NFZ oncology contracts.
• Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie (National Cancer Institute, Warsaw): Poland's premier oncology reference center and the national SOLO III designation holder. Comparable as a comprehensive oncology hospital providing diagnostics, surgery, chemotherapy, radiotherapy, and clinical trials. Sets the benchmark for oncology service value that Rydygier aspires to regionally.
• Szpital im. Jana Pawła II w Krakowie: Consortium partner within Onkologia Małopolska and direct regional competitor in Krakow for cardiac and thoracic surgery, oncology, and tertiary referrals. Similar scale and public ownership structure, competing for the same NFZ contracts and patient catchment in southern Poland.
• Szpital Uniwersytecki w Krakowie (Krakow University Hospital): Major multi-specialty academic hospital in Krakow with similar scale, teaching/research mission, and comprehensive specialty coverage. Direct competitor for tertiary referrals in Małopolska, particularly in oncology and surgery where both compete for NFZ contracts and specialist staff.

Regional players

• Uniwersyteckie Centrum Kliniczne im. prof. Kornela Gibińskiego (Katowice): Major multi-specialty academic hospital in neighboring Silesia region with similar scope (oncology, surgery, multi-specialty). Comparable in scale and academic teaching mission; competes for cross-regional referrals and high-complexity cases in southern Poland.
• American Heart of Poland (Centrum Kardiologii Inwazyjnej i Angiologii): Poland's largest private cardiology network, partially owned by foreign investors. While focused on cardiology rather than Rydygier's oncology-heavy mix, it represents the private healthcare model that competes for medical talent and commercial patients in southern Poland.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/tweet_rydygier
• Facebookfacebook.com/profile.php

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie